Cipher Intangible Assets from 2010 to 2026

CPH Stock  CAD 14.80  0.10  0.68%   
Cipher Pharmaceuticals Intangible Assets yearly trend continues to be very stable with very little volatility. Intangible Assets are likely to grow to about 95.1 M this year. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
2006-12-31
Previous Quarter
75.3 M
Current Value
73.6 M
Quarterly Volatility
20.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Cipher Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cipher Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.9 M, Interest Expense of 506.9 K or Selling General Administrative of 8.8 M, as well as many indicators such as Price To Sales Ratio of 14.31, Dividend Yield of 0.0458 or PTB Ratio of 5.25. Cipher financial statements analysis is a perfect complement when working with Cipher Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Cipher Pharmaceuticals Technical models . Check out the analysis of Cipher Pharmaceuticals Correlation against competitors.

Latest Cipher Pharmaceuticals' Intangible Assets Growth Pattern

Below is the plot of the Intangible Assets of Cipher Pharmaceuticals over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Cipher Pharmaceuticals' Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cipher Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Intangible Assets10 Years Trend
Slightly volatile
   Intangible Assets   
       Timeline  

Cipher Intangible Assets Regression Statistics

Arithmetic Mean22,795,870
Geometric Mean8,697,126
Coefficient Of Variation145.07
Mean Deviation25,805,538
Median5,400,000
Standard Deviation33,069,090
Sample Variance1093.6T
Range93.6M
R-Value0.61
Mean Square Error729T
R-Squared0.38
Significance0.01
Slope4,010,507
Total Sum of Squares17497T

Cipher Intangible Assets History

202695.1 M
202590.6 M
202478.8 M
20231.8 M
20222.8 M
20213.6 M
20204.2 M

About Cipher Pharmaceuticals Financial Statements

Cipher Pharmaceuticals investors utilize fundamental indicators, such as Intangible Assets, to predict how Cipher Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Intangible Assets90.6 M95.1 M

Other Information on Investing in Cipher Stock

Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.